Related Experiment Video
Updated: May 15, 2026
07:23
Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice
Published on: December 20, 2024
HIV-associated dementia: A diagnostic dilemma
Daniel Saldanha1, Sumit Beniwal, Labanya Bhattacharya
1Department of Psychiatry, Padm Dr. DY Patil Medical College, Sant Tukaram Nagar, Pimpri, Pune, India.
Industrial Psychiatry Journal
|December 29, 2012
Summary
This study investigated HIV Associated Dementia (HAD) incidence in India, finding a low rate of HAD stage II among HIV-positive individuals. Antiretroviral therapy significantly reduced morbidity in the HIV-infected population.
Area of Science:
- Neurology
- Infectious Diseases
- Public Health
Background:
- HIV infection has significant neuropathological implications.
- Understanding HIV Associated Dementia (HAD) is crucial for patient care.
- Research is ongoing to elucidate the impact of HIV on the brain.
Purpose of the Study:
- To determine the incidence of HIV Associated Dementia (HAD) in a suburban Indian population.
- To assess the prevalence of neurological and psychiatric symptoms in HIV-positive individuals.
- To evaluate the effectiveness of treatment on HIV-related neurological complications.
Main Methods:
- A prospective study involving 6135 individuals undergoing pretest counseling for HIV from January 2008 to August 2010.
- HIV testing was performed using the Western blot test for consenting participants.
- Neurological and psychiatric assessments were conducted on HIV-positive individuals.
Main Results:
- Out of 6135 participants, 5688 (92.71%) were tested for HIV, with 273 (4.8%) testing positive.
- 246 (90.10%) of HIV-positive individuals were initiated on Antiretroviral Therapy (ART).
- One participant (0.37%) was diagnosed with HAD stage II, and 38 (18.92%) presented with various psychiatric symptoms.
Conclusions:
- Highly Active Antiretroviral Therapy (HAART) has substantially decreased HIV-related morbidity.
- The incidence of HAD appears low in this specific Indian cohort.
- Early diagnosis and treatment are vital for managing HIV and its neurological complications.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...